Regardless, the semaglutide base is being manufactured by FDA-approved manufacturers and is available to compounding pharmacies
No one knows what ten or twenty years on GLP-1s will look likein real bodies, in everyday lives
To assess the association of semaglutide with incident CUD, the study population included 587,849 patients with T2D who had active medical encounters for T2D during 12/20175/2021, were for the first time prescribed semaglutide (Ozempic) or non-GLP1-1RA anti-diabetes medications (new-user design) during 12/20175/2021(index event), had no diagnosis of CUD on or before the index event and had a diagnosis of at least one of obesity-associated comorbidities (T2D, hypertension, hypercholesterolemia, hyperlipidemia, heart diseases, stroke) on or before the index event
Gastrointestinal Symptoms: Nausea, vomiting, or diarrhea can lead to dehydration and nutrient loss, which may cause tiredness
You take a genuinely exciting area of science and overstate and misrepresent it to sell bunk, Caulfield said
2026 Ozempic NAION Lawsuit Updates March 3, 2026 Update: The judge overseeing the federal GLP-1 vision loss litigation selected a group of plaintiffs attorneys to manage discovery and other coordinated pretrial matters involving claims that Ozempic, Wegovy and similar drugs caused permanent vision damage